Product Description
139264-17-8 Zolmitriptan API refers to the active pharmaceutical ingredient (API) of the medication zolmitriptan. It belongs to the class of drugs known as triptans, which are specifically designed to target serotonin receptors in the brain to alleviate migraine symptoms. Zolmitriptan is a selective serotonin receptor agonist used in the treatment of acute migraine attacks with or without aura in adults. 139264-17-8 Zolmitriptan API serves as the active component responsible for the therapeutic effects of zolmitriptan and is used as the basis for the formulation of various dosage forms such as tablets, orally disintegrating tablets, or nasal sprays for administration to patients experiencing migraine attacks.